{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.199","meta":{"versionId":"6","lastUpdated":"2021-05-21T01:00:57.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.199","version":"20210521","name":"Trastuzumab Emtansine Injectable","status":"active","date":"2021-05-21T01:00:57-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1658084","display":"ado-trastuzumab emtansine 100 MG Injection"},{"code":"1658089","display":"ado-trastuzumab emtansine 160 MG Injection"}]}]},"expansion":{"identifier":"urn:uuid:1a297602-653d-4dee-843a-5bfb81ae58be","timestamp":"2022-06-10T12:38:42-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1658084","display":"ado-trastuzumab emtansine 100 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1658089","display":"ado-trastuzumab emtansine 160 MG Injection"}]}}